Recommendations on the clinical use of B-type natriuretic peptide testing (BNP or NTproBNP) in the UK and Ireland

British Journal of Cardiology

Volumn 17, Issue 2, 2010, Pages 76-80

  Cowie, Martin R ^a   Collinson, Paul O ^b   Dargie, Henry ^c   Hobbs, F D Richard ^d   McDonagh, Theresa A ^e   McDonald, Kenneth ^f   Rowell, Nigel ^g  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^g Endeavour Practice   (United Kingdom)

Author keywords

B type natriuretic peptide testing; Consensus; Heart failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART FAILURE; BODY MASS; CONSENSUS DEVELOPMENT; DRUG MONITORING; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; IRELAND; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SEX; UNITED KINGDOM;

EID: 77958087421     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Healthcare Commission. Pushing the boundaries: improving services for people with heart failure. London: Healthcare Commission, 2007.
2. Mant J, Doust J, Roalfe A et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009;13(32).
3. Craig J, Bradbury I, Cummins E et al. The use of B-type natriuretic peptides (BNP and NT-proBNP) in the investigation of patients with suspected heart failure. Glasgow: NHS Quality Improvement Scotland, 2005.
4. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
5. Januzzi JL, Van Kimmenade R, Lainchbury J et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilised heart failure: an international pooled analysis of 1256 patients. Eur Heart J 2006;27:330-7.
6. Fuat A, Murphy JJ, Hungin APS et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 2006;56:327-33.
7. Hildebrandt P, Collinson PO. Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients. Am J Cardiol 2008; 101:25A-28A.
8. Lim TK, Collinson PO, Celik E, Gaze D, Senior R. Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failure. Int J Cardiol 2007;115:73-4. (Pubitemid 44855170)
9. Collinson PO. The cost effectiveness of B-type natriuretic peptide measurement in the primary care setting - a UK perspective. Congest Heart Fail 2006;12:103-07.
10. Galasko GIW, Barnes SC, Collinson P et al. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 2006;27:193-200.
11. Mueller C, Laule-Kilian K, Schindler C et al. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med 2006;166:1081-7. (Pubitemid 43765179)
12. Fonarow GC, Peacock WF, Phillips CO et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007;49:1943-50.
13. Maisel A, Hollander JE, Guss D et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicentre study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004;44:1328-33.
14. Bettencourt P, Azevedo A, Pimenta J et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-74.
15. Logeart D, Thabut G, Jourdain P et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-41.
16. Cheng V, Kazanagra R, Garcia A et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-91.
17. Valle R, Aspromonte N, Giovinazzo P et al. B-type natriuretic peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. J Cardiac Fail 2008;14:219-24.
18. Gardner RS, McDonagh TA, MacDonald M et al. Who needs a heart transplant? Eur Heart J 2006;27:770-2.
19. Berger R, Huelsman M, Strecker K et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-7.
20. Pfisterer M, Buser P, Rickli H et al. BNP-guided vs symptom-guided heart failure therapy. The trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial. JAMA 2009;301:383-92.
21. Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009;158:422-30.
22. O'Hanlon R, O'Shea P, Ledwidge M et al. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Cardiac Fail 2007;13:50-5.
23. Miller WL, Hartman KA, Grill DE et al. Only large reductions in concentration of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. Clin Chem 2009;55:78-84.
24. McDonagh TA, Robb SD, Murdoch DR et al. Biochemical detection of leftventricular systolic dysfunction. Lancet 1998;351:9-13. (Pubitemid 28020159)
25. Krauser DG, Lloyd-Jones DM, Chae CU et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a proBNP investigation of dyspnea in the emergency department (PRIDE) substudy. Am Heart J 2005;149:744-50.
26. Frankenstein L, Remppis A, Nelles M et al. Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur Heart J 2008;29:2634-40.
27. Dickstein K, Cohen-Solal A, Filippatos G et al. European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442.